The Current Ratio as of November 2024 (TTM) for First Wave BioPharma, Inc. (FWBI) is 1.21

According to First Wave BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.21. This represents a change of -5.19% compared to the average of 1.28 of the last 4 quarters.

First Wave BioPharma, Inc. (FWBI) Historical Current Ratio (quarterly & annually)

How has FWBI Current Ratio performed in the past?

The mean historical Current Ratio of First Wave BioPharma, Inc. over the last ten years is 0.92. The current 1.21 Current Ratio has changed 13.11% with respect to the historical average. Over the past ten years (40 quarters), FWBI's Current Ratio was at its highest in in the September 2020 quarter at 4.39. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

First Wave BioPharma, Inc. (FWBI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of First Wave BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

First Wave BioPharma, Inc. (FWBI) Average Current Ratio

How has FWBI Current Ratio performed in the past?

The current Current Ratio of First Wave BioPharma, Inc. (FWBI) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

First Wave BioPharma, Inc. (FWBI) Current Ratio vs. Peers

How is FWBI’s Current Ratio compared to its peers?

First Wave BioPharma, Inc.’s Current Ratio is less than Quoin Pharmaceuticals, Ltd. (3.02), greater than Blue Water Vaccines, Inc. (0.54), greater than PaxMedica, Inc. Common Stock (0.38), less than Revelation Biosciences, Inc. (1.64), less than Hillstream BioPharma, Inc. (2.25), less than Dermata Therapeutics, Inc. (7.11), greater than Panbela Therapeutics, Inc. (0.26), greater than ContraFect Corporation (0.53), greater than SeaStar Medical Holding Corporation (0.54), less than Virios Therapeutics, Inc. (7.27), greater than ZyVersa Therapeutics, Inc. (0.03), less than Sonnet BioTherapeutics Holdings, Inc. (1.65), less than Cardio Diagnostics Holdings, Inc. (8.51), less than Sigilon Therapeutics, Inc. (2.40), less than X4 Pharmaceuticals, Inc. (4.89), less than Zura Bio Limited (10.36), less than Apexigen, Inc. (1.29), less than Phio Pharmaceuticals Corp. (6.38), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Immix Biopharma, Inc. (3.47),

Build a custom stock screener for First Wave BioPharma, Inc. (FWBI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like First Wave BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

First Wave BioPharma, Inc. (FWBI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like First Wave BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.